AzTrials
AzTrials

Elective Colorectal SurgeryIBIPNCT02756273

Impact of a Bridge Device on the Loop Ileostomy

A study testing bridge device and no bridge device in people with Elective Colorectal Surgery, run by Centre Hospitalier Universitaire, Amiens at 3 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

During the creation of an ileostomy, a bridge device is systematically placed in an aim to reduce wound and peritoneal contamination by stools. Nevertheless no evidence was reported to justify this issue. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Elective Colorectal Surgery
What is being tested?
bridge device and no bridge device
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
166 participants
Where
3 sitesFrance
Study dates
9 May 2016to 9 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • colorectal disease (cancer; diverticulitis; Crohn disease; inflammatory bowel disease)
  • requiring elective surgery with an ileostomy
  • patient having given his consent before the enrollment

Who cannot join

  • patient with early closure of the stoma (within 10 days after the colorectal surgery)
  • long term corticoids
  • emergency surgery
  • history of stoma in the side of the stoma placement planned for the study
  • BMI >50
  • No signature of the consent to participate in the study
Show all 17Show fewer
  • Physical or mental state not allowing participation in the study
  • Contraindication to surgery
  • ASA classification (American Society of Anesthesiologists) IV-V or life expectancy <48h
  • Pregnancy or breastfeeding
  • Patient under guardianship or guardianship or patient deprived of liberty by a judicial or administrative decision (in accordance with articles L1121-6 and L1121-8 of the Public Health Code)
  • Minor patient
  • Patient without social protection
  • Peroperative exclusion criteria:
  • no anastomosis
  • no ileostomy
  • Spontaneous stomal retraction

Trial locations and contacts

3 sites in 1 country.

France3 sites
  • Amiens Universitary Hospital

    Amiens

  • Beauvais hospital

    Beauvais

  • Chu Rouen

    Rouen, France, 76000

Other trials in France

About this study

During the creation of an ileostomy, a bridge device is systematically placed in an aim to reduce wound and peritoneal contamination by stools. Nevertheless no evidence was reported to justify this issue.

Moreover the placement of a bridge device increases the difficulty of nurse cares and is associated with its own morbidity.

Being tested
bridge device, no bridge device
Keywords
ileostomy, morbidity, colorectal surgery

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • bridge deviceDevice

  • no bridge deviceDevice

Study groups in NCT02756273
Study groupRoleWhat they receive
no bridge deviceExperimentalAfter the ileostomy creation, no bridge device was placed.
Receives: Device: no bridge device
bridge deviceActive comparatorA bridge device was placed after the stoma creation.
Receives: Device: bridge device

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. absence of postoperative morbidity

    the primary outcome is a composite score. The complication is considered as present if the patient experienced at least one of the following events: surgical site infection (either superficial, deep or distant); a parastomal irritation; a stomal necrosis; parastomal hernia; a stoma stenosis; a stoma prolapsus or a stoma leakage. The primary endpoint is evaluated by a nurse devoted to stoma care according to an open label.

    Measured: two months after the surgery

Secondary outcomes (7)
  1. difficulty of the stoma conception

    the difficulty was assessed by the surgeon thanks to a score ranging from 1 to 10.

    Measured: at the end of the surgery

  2. the reoperation rate

    the reoperation rate is defined as the number of reoperation one month after the colorectal surgery

    Measured: postoperative month one

  3. the mortality rate

    the mortality rate is defined as the number of deaths one month after the surgery

    Measured: postoperative month one

  4. the postoperative morbidity

    the postoperative morbidity is defined according the Clavien - Dindo classification and corresponds to the number of patients with a postoperative outcome

    Measured: postoperative month one

  5. the specific quality of life

    the quality of life is assessed with the STOMA QoL form at Baseline, 2, 6 months after the surgery and one year after the surgery

    Measured: postoperative year one

  6. the rate of stoma closure

    the rate of stoma closure is defined as the number of patients for whom the stoma was closed 6 months after the colorectal surgery.

    Measured: 6 months after the surgical procedure

  7. the rate of anastomotic fistula

    the rate of anastomotic fistula is defined as the number of anastomotic fistula after the colorectal surgery.

    Measured: 2 months after the colorectal surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Apr 2016 (estimated)
  2. Study start9 May 2016
  3. Primary completion9 Dec 2025
  4. Study completion9 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
166 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02756273
Sponsor's protocol ID
PI2015_843_0008
Other IDs
2015-A00620-49, 2015/29
Acronym
IBIP
Status last verified
Jun 2026
First submitted
27 Apr 2016
Last updated
11 Jun 2026
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Matthiessen P, Hallbook O, Rutegard J, Simert G, Sjodahl R. Defunctioning stoma reduces symptomatic anastomotic leakage after low anterior resection of the rectum for cancer: a randomized multicenter trial. Ann Surg. 2007 Aug;246(2):207-14. doi: 10.1097/SLA.0b013e3180603024.

    PubMed 17667498
  • Sagap I, Remzi FH, Hammel JP, Fazio VW. Factors associated with failure in managing pelvic sepsis after ileal pouch-anal anastomosis (IPAA)--a multivariate analysis. Surgery. 2006 Oct;140(4):691-703; discussion 703-4. doi: 10.1016/j.surg.2006.07.015.

    PubMed 17011918
  • Panis Y, Maggiori L, Caranhac G, Bretagnol F, Vicaut E. Mortality after colorectal cancer surgery: a French survey of more than 84,000 patients. Ann Surg. 2011 Nov;254(5):738-43; discussion 743-4. doi: 10.1097/SLA.0b013e31823604ac.

    PubMed 21997816
  • Oberkofler CE, Rickenbacher A, Raptis DA, Lehmann K, Villiger P, Buchli C, Grieder F, Gelpke H, Decurtins M, Tempia-Caliera AA, Demartines N, Hahnloser D, Clavien PA, Breitenstein S. A multicenter randomized clinical trial of primary anastomosis or Hartmann's procedure for perforated left colonic diverticulitis with purulent or fecal peritonitis. Ann Surg. 2012 Nov;256(5):819-26; discussion 826-7. doi: 10.1097/SLA.0b013e31827324ba.

    PubMed 23095627
  • Cottam J, Richards K, Hasted A, Blackman A. Results of a nationwide prospective audit of stoma complications within 3 weeks of surgery. Colorectal Dis. 2007 Nov;9(9):834-8. doi: 10.1111/j.1463-1318.2007.01213.x. Epub 2007 Aug 2.

    PubMed 17672873
  • Sabbagh C, Mauvais F, Demouron M, Browet F, Tartar L, Hariz H, Bridoux V, Tuech JJ, Diouf M, Regimbeau JM. Is a bridge (rod) necessary for loop ileostomy? A phase II randomized control trial. Tech Coloproctol. 2025 Mar 25;29(1):87. doi: 10.1007/s10151-025-03132-4.

    PubMed 40131588

Questions about this trial

What is this clinical trial studying?

A study testing bridge device and no bridge device in people with Elective Colorectal Surgery, run by Centre Hospitalier Universitaire, Amiens at 3 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

absence of postoperative morbidity (time frame: two months after the surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02756273, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in